方法：对552眼行标准化及个性化LASEK手术，术后戴软性角膜接触镜，点1g/L氟米龙滴眼液、左氧氟沙星滴眼液及重组牛碱性成纤维细胞生长因子眼药水，5～7d后摘除角膜接触镜、加用重组牛碱性成纤维细胞生长因子眼用凝胶，术后1，7d； 1，3，6mo； 1，2a复查。

结果：裸眼视力≥1.0患者480眼(87.0%)，<1.0～0.8者62眼(11.2%)，<0.8～0.6者10眼(1.8%)。

结论：LASEK疗效好、安全性高，是治疗近视、尤其是低中度近视的可靠方法。

METHODS: Totally 552 eyes underwent standard and personalized LASEK surgery, used soft contact lens, and 1g/L fumilone eye-drops, levofloxacin eye-drops and bFGF eye-drops after surgery, and 5 to 7 days later, soft contact lens was removed and bFGF eye gel was added, the eyes were reviewed after 1 day, 7 days, 1 month, 3 months, 6 months and 1 year.

RESULTS: Uncorrected vision ≥1.0 in 480 eyes(87.0%), <1.0-0.8 in 62 eyes(11.2%), <0.8-0.6 in 10 eyes(1.8%).

CONCLUSION: LASEK is an effective, safe, reliable treatment for myopia, especially for low-middle myopia.